Takeda’s Hib Vaccine to Be Reported to PAC in December

Takeda Pharmaceutical’s Hib vaccine (precipitated vaccine for Haemophilus type B (conjugated to a non-toxic variant of diphtheria toxin)) is due to be reported to the Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Pharmaceutical Affairs Council (PAC) in December. The vaccine...read more